Spotlight Asset Group »

Relmada Therapeutics shares owned by Spotlight Asset Group

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Spotlight Asset Group from 13F filings

Historical chart of Spotlight Asset Group investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Spotlight Asset Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Spotlight Asset Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $60k 20k 3.00
2023-09-30 $60k 20k 3.00
2023-06-30 $49k 20k 2.46
2023-03-31 $140k 20k 7.00
2022-09-30 $140k 20k 7.00
2021-09-30 $793k 30k 26.20
2021-06-30 $969k 30k 32.02
2021-03-31 $865k 25k 35.21
2020-12-31 $728k 23k 32.06